Everolimus effective in women with early failure of adjuvant therapy Ob.Gyn. News Digital Network SAN FRANCISCO – In patients who had hormone receptor–positive, HER2-negative advanced breast cancer, everolimus plus exemestane was just as effective among women who had a recurrence during or within a year of adjuvant therapy. The results ... |
